Ankylosing spondylitis is a type of inflammatory arthritis primarily affecting the spine and sacroiliac joints. It causes chronic pain and stiffness in the lower back and can lead to fusion of spinal vertebrae. It is more common in men.
Adalimumab is a TNF inhibitor biologic that blocks tumor necrosis factor-alpha to reduce inflammation in rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
Etanercept is a TNF inhibitor biologic that blocks tumor necrosis factor-alpha to reduce inflammation in rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
Infliximab is a TNF inhibitor biologic that blocks tumor necrosis factor-alpha to reduce inflammation in rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
Golimumab is a TNF inhibitor biologic that blocks tumor necrosis factor-alpha to reduce inflammation in rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
Certolizumab is a TNF inhibitor biologic that blocks tumor necrosis factor-alpha to reduce inflammation in rheumatoid arthritis, psoriasis, and inflammatory bowel disease.
Describe your symptoms and get a structured AI clinical assessment — possible causes, urgency level, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: